Comparison of oseltamivir and α-galactosylceramide for reducing disease and transmission in pigs infected with 2009 H1N1 pandemic influenza virus

Comparison of oseltamivir and α-galactosylceramide for reducing disease and transmission in pigs infected with 2009 H1N1 pandemic influenza virus

Influenza virus infections are a major cause of respiratory disease in humans. Neuraminidase inhibitors (NAIs) are the primary antiviral medication used to treat ongoing influenza infections. However, NAIs are not always effective for controlling virus shedding and lung inflammation. Other concerns...

Full description

Bibliographic Details
Main Authors: Darling Melany de C. Madrid, Weihong Gu, Bianca L. Artiaga, Guan Yang, Julia Loeb, Ian K. Hawkins, William L. Castleman, John A. Lednicky, Jürgen A. Richt, John P. Driver
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Veterinary Science
Subjects:
α-galactosylceramide
antiviral
invariant natural killer T-cells
oseltamivir
swine
influenza
Online Access:https://www.frontiersin.org/articles/10.3389/fvets.2022.999507/full

Similar Items

Similar Items